JPS5373595A - Cephalospoline derivative process for preparing same and medicine containing same - Google Patents

Cephalospoline derivative process for preparing same and medicine containing same

Info

Publication number
JPS5373595A
JPS5373595A JP14729477A JP14729477A JPS5373595A JP S5373595 A JPS5373595 A JP S5373595A JP 14729477 A JP14729477 A JP 14729477A JP 14729477 A JP14729477 A JP 14729477A JP S5373595 A JPS5373595 A JP S5373595A
Authority
JP
Japan
Prior art keywords
same
cephalospoline
medicine containing
derivative process
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14729477A
Other languages
English (en)
Inventor
Kiizeuetsuteru Eruuin
Miyutsukuteru Hainritsuhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of JPS5373595A publication Critical patent/JPS5373595A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
    • C07D499/58—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
    • C07D499/62—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP14729477A 1976-12-10 1977-12-09 Cephalospoline derivative process for preparing same and medicine containing same Pending JPS5373595A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762655949 DE2655949A1 (de) 1976-12-10 1976-12-10 Neue cephalosporin- und penicillinderivate, verfahren zu deren herstellung und diese produkte enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
JPS5373595A true JPS5373595A (en) 1978-06-30

Family

ID=5995155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14729477A Pending JPS5373595A (en) 1976-12-10 1977-12-09 Cephalospoline derivative process for preparing same and medicine containing same

Country Status (7)

Country Link
US (1) US4159327A (ja)
JP (1) JPS5373595A (ja)
BE (1) BE861721A (ja)
DE (1) DE2655949A1 (ja)
FR (1) FR2378787A1 (ja)
GB (1) GB1560326A (ja)
NL (1) NL7713290A (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322347A (en) * 1978-04-03 1982-03-30 Bristol-Myers Company 2-Carbamoyloxymethyl-penicillin derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH557381A (de) * 1967-04-15 1974-12-31 Fujisawa Pharmaceutical Co Verfahren zur herstellung von (delta)3-cephemverbindungen.
US3422100A (en) * 1967-05-02 1969-01-14 Bristol Myers Co S-substituted-thioacetamido-cephalosporins
US3948906A (en) * 1967-08-21 1976-04-06 Glaxo Laboratories Limited Cephalosporin compounds
US3922268A (en) * 1969-12-08 1975-11-25 Lilly Co Eli 3-Halomethyl-{66 {hu 3-Cephalosporin esters
GB1478055A (en) * 1973-07-27 1977-06-29 Erba Carlo Spa Cephalosporin compounds
AR207960A1 (es) * 1973-10-03 1976-11-22 Fujisawa Pharmaceutical Co Procedimiento para preparar un acido 7-(acetamido-2-sustituido)-3-cefem-4-carboxilico y sus sales
US4042585A (en) * 1976-03-22 1977-08-16 Eli Lilly And Company Process for preparation of 3-halomethylcephems

Also Published As

Publication number Publication date
DE2655949A1 (de) 1978-06-15
FR2378787B1 (ja) 1981-07-24
US4159327A (en) 1979-06-26
NL7713290A (nl) 1978-06-13
FR2378787A1 (fr) 1978-08-25
BE861721A (fr) 1978-03-31
GB1560326A (en) 1980-02-06

Similar Documents

Publication Publication Date Title
JPS5324033A (en) Allergenncontainig substance and process for preparing same
JPS52122632A (en) Medical composition and process for preparing same
JPS5340740A (en) Prostanate derivative process for preparing same and pharmacy containing same and having prostagradine action
JPS5387399A (en) Benzocycloheptapyrazolopyridine derivative and process for preparing same
JPS52125193A (en) Indolysine derivatives process for preparing same and medicine containing same
JPS52118493A (en) Cephalospoline derivatives and process for preparing same
IL52611A0 (en) 2-benzylpyrrolidines process for their preparation and medicaments containing them
HU178340B (en) Process for preparing new pharmaceutical preparations containing aryloxy-alkanolamine and monoalkylsulphate
JPS5287192A (en) 77aminothiazolylacetoamid cephalospolanate derivatives process for preparing same and pharmaceutical composition
JPS5436225A (en) Novel 1*33diphenoxypropanee22one derivative process for preparing same and medicine containing same
JPS52111593A (en) 99substitutedd88azapurine and process for preparing same
JPS53141230A (en) Aminoalcohol derivative process for preparing same and medicine containing same
JPS52125198A (en) Naphtilysine derivatives and process for preparing same
JPS53103470A (en) 33phenylloxazolidinee2*44dions process for preparing same and moldicide containing same
JPS52102295A (en) Amidinopenicillanoyloxyalkyl cephalospolanates process for preparing same and pharmacy containing same
JPS53130682A (en) Novel 11*33*3*4*55trimethoxyphenoxy**22 hydroxyypropyl**44aryllpiperazine derivative process for preparing same and medicine containing same
JPS5365880A (en) Cydononeimineeacyl derivative and process for preparing same
JPS5379875A (en) Basically substituted novel propyloxime process for preparing same and medical application thereof
JPS5395956A (en) Novel heleprigeninacyl derivative process for preparing same and cordially active medicine containing same
JPS52144659A (en) 22chloroo66methyll44benzylphenol and process for preparing same
JPS52148096A (en) Medicine novel heterocyclic compound containing therein and process for preparing same
JPS52153997A (en) Novel aminopropanol derivatives process for preparing same and medicine having betaareceptor interrupting activity containing same
JPS537649A (en) Process for preparing prostaglandineea and certain derivatives
JPS5384969A (en) Benzisothiazolon process for preparing same and medical composition containing same
JPS5373595A (en) Cephalospoline derivative process for preparing same and medicine containing same